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Background: Improvements in surgical technique cannot eliminate the risk of hypocalcemia. We aimed
to evaluate the accuracy of PTH levels in surgical site irrigation ﬂuid (irPTH) in predicting patients at risk
for postoperative hypocalcemia.
Methods: Prospective analysis of 160 consecutive patients undergoing thyroidectomy was performed.
Patients were divided into 2 groups based on postoperative serum calcium levels. Patients with hypo-
calcemia were assigned to Group 1 (n¼ 38), while those with normocalcemia were assigned to Group 2
(n¼ 122). Preoperative and postoperative serum calcium levels and PTH level of surgical site irrigation
ﬂuid (irPTH), and the difference in serum calcium levels before and after thyroidectomy were
determined.
Results: The difference in serum calcium levels and irPTH levels in Group 1 were signiﬁcantly higher than
those in group 2 (p¼ 0.001). There was a negative correlation between postoperative serum calcium level
and irPTH level (r¼0.641, p¼ 0.0001). Patients who had irPTH level higher than 250 pg/mL had
a 69-fold increased risk for postoperative hypocalcemia (OR¼ 69.88; 95% CI: 15.37–309.94).
Conclusions: High irPTH level is signiﬁcantly associated with postoperative hypocalcemia. The irPTH
assay is sufﬁcient to identify hypocalcemia in the majority of patients and it is a sensitive tool to identify
patients at risk of developing postoperative hypocalcemia.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Background Recently, several studies investigated the reliability of intra-Thyroidectomy is one of the most frequent operations per-
formed in iodine-deﬁcient regions.1–3 The most common compli-
cations of thyroidectomy include vocal cord palsy and
hypocalcemia.4,5 Hypocalcemia is frequently encountered after
thyroidectomy and it continues to challenge even the experienced
surgeon. The incidence of postoperative hypocalcemia is reported
to vary from 1.6% to above 50%.4–9 The etiology of hypoparathy-
roidism seems to be a multifactorial phenomenon but the most
important factors can be listed as the iatrogenic surgical trauma
and devascularization to parathyroid glands, the extent of surgery,
the experience of the surgeon and the number of functioning
glands left behind.4,6,10,11 Although efforts were made to identify
clinical and pathologic risk factors for the development of hypo-
calcemia after thyroidectomy, advancements so far lack an ideal
perioperative assessment of parathyroid function.12–14: þ90 212 5331784.
ciates Ltd. Published by Elsevier Ltoperative or postoperative serum parathormone (PTH) measure-
ments in predicting hypocalcemia after thyroidectomy and
decreased serum PTH levels were found early predictive of post-
operative hypocalcemia.15–22
2. Aim of the study
The aim of this prospective clinical study is to evaluate the
accuracy of PTH levels in surgical site irrigation ﬂuid (irPTH) in
predicting patients at risk for postoperative hypocalcemia. To our
knowledge, this is the ﬁrst prospective study performed to detect
the irPTH level in predicting postoperative hypocalcemia.
3. Patients and methods
3.1. Patients
A total of 160 consecutive patients who underwent total
thyroidectomy (TT) and near total thyroidectomy (NTT) in Generald. All rights reserved.
Table 1
A comparison of demographic and laboratory features in patients with control and
study group.
Study group
(n¼ 160)
Control group
(n¼ 50)
p
Demographic
and clinical
features
Age 46.4 12 47.1 13 NS
F:M 9:1 7.3:1 NS
Preoperative serum Ca level
(mg/dL)
9.3 0.4 9.2 0.3 NS
Preoperative serum PTH level
(mg/dL)
37.7 13 36.6 12 NS
The ratio of total thyroidectomy 69% 70% NS
Experienced endocrine surgeon 87.5% 80% NS
Surgical
indications
Multinodular goiter 41.8% 38% NS
Multinodular toxic goiter 29.3% 28% NS
Graves disease 13.7% 20% NS
Carcinoma 15% 14% NS
Abbreviations: F: female, M: male, PTH: parathormone.
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between November 2007 and June 2008 were included prospec-
tively in the present study.
The main indications for surgery included Graves disease,
thyroid carcinoma, multinodular toxic goiter, and large goiter with
a compressive effect. Patients with concomitant parathyroid
disease, patients in whom accidental removal of one or more
parathyroid glands occurred (either identiﬁed in the pathology
report or identiﬁed intraoperatively), patients undergoing reoper-
ative thyroid surgery and central neck and/or lateral neck lymph
node dissection as well as those who refused to participate were
excluded from the present study. None of the patients had signs or
symptoms indicating metabolic bone disease and none of the
patients were on medications known to affect serum calcium
metabolism such as oral calcium/vitamin D supplementation,
antiresorptive agents, hormone replacement therapy for post-
menopausal women, anabolic agents, thiazide type diuretics and
antiepileptic agents. The study planwas reviewed and approved by
our institutional ethical committee, and informed consent was
obtained from all patients.
All thyroid procedures were performed by experienced surgeons
and by 4th year residents in training under the supervision of an
experienced surgeon using the conventional clamp-and-tie tech-
nique. Vessel sealing systems including ultrasonic dissectors, elec-
trothermal bipolar vessel sealers, and titanium clips were not used.
Total thyroidectomywasperformedbyextracapsular dissection. Near
total thyroidectomy was performed by the capsular dissection
method, and less than 1 g of remnant tissuewas left around the Berry
ligament. For the remnant tissue, we estimated that 1 cm3 equaled
1 g. Recurrent laryngeal nerves were carefully identiﬁed and
dissected. All parathyroid glands identiﬁed and preserved with
meticulous dissection for their blood supply.
The surgical site was irrigated by saline solution (50 ml/
patient) after thyroidectomy. The irrigant was aspirated by sterile
syringe (10 ml). PTH level of the surgical site irrigation ﬂuid
(irPTH) was measured. Serum calcium and PTH levels were
determined the day before surgery and serum calcium was
measured 24 h postoperatively. Serum calcium concentration was
adjusted for serum albumin. The difference in serum calcium
levels before and after thyroidectomy was calculated. Fifty
patients were assigned to a control group. Before thyroidectomies
were performed, surgical site was irrigated by saline solution
(50 ml/patient). irPTH was also measured. The surgical indications
of control group also included Graves disease, thyroid carcinoma,
multinodular toxic goiter, and large goiter with a compressive
effect.
One hundred sixty patients were divided into two groups
according to postoperative calcium level. Patients in Group 1
(n¼ 38) had postoperative serum calcium level 8 mg/dL,
whereas patients in Group 2 (n¼ 122) had serum calcium level
>8 mg/dL. Hypocalcemia was deﬁned as serum calcium concen-
tration 8 mg/dL. Asymptomatic hypocalcemia was determined
with laboratory ﬁndings alone whereas laboratory ﬁndings
accompanied by clinical symptoms were referred to as symp-
tomatic hypocalcemia. Presence of clinical symptoms or signs of
hypocalcaemia were reported and included as facial paresthesia,
positive Chvostek’s signs, and muscular spasm. Serum calcium
levels of hypocalcemic patients were measured every 12 h until
the day they were stabilized. Patients who developed asymp-
tomatic hypocalcemia were treated with oral calcium (3–6 g/
day), while those with symptomatic hypocalcemia were treated
with parenteral calcium and an oral 1,25-dihydroxy vitamin D3
(calcitriol) supplementation of 1–1.5 mg/day. Patients with
asymptomatic hypocalcemia were discharged on oral calcium,
whereas patients with symptomatic hypocalcemia weredischarged on oral calcium and/or calcitriol at doses modiﬁed in
relation to serum calcium concentration and were followed up
weekly until their serum calcium and PTH levels were
normalized.
3.2. Biochemical analysis
Serum calcium levels were determined by auto-analyzer (Cobas
Integra 800, Roche Diagnostics, Basel, Switzerland). Serum PTH and
surgical site irrigation ﬂuid PTH levels were determined by
immunoradiometric assay using commercially available kitsdthe
PTH-120 min-IRMA kit (BioSource Europe S.a, Nivelles, Belgium).
Normal ranges of biochemical parameters were 8.5–10.5 mg/dL for
serum calcium and 10–65 pg/mL for serum PTH concentrations.
3.3. Statistics
Data were analyzed using SPSS 11.0 for Windows. Results were
expressed as mean SD. Comparisons of data were performed by
Mann–Whitney-U, Wilcoxon, Student-t and chi-squared tests.
Receiver operating characteristic (ROC) curves were designed to
identify the cut-off values for irPTH level and the difference of
serum calcium level before and after thyroidectomy. Correlation
analysis of continuous variables was performed using Spearman’s
rank test. Results were considered statistically signiﬁcant when the
two-tailed p value was less than 0.05.
4. Results
4.1. Patients
The mean SD age was 46.412 years (range, 20–77 years) for
160 patients. The female to male ratio was 9:1 (n¼ 144 and 16,
respectively). The mean SD for preoperative serum calcium and
PTH levels, postoperative serum calcium, irPTH, and the post-
operative drop in serum calcium level were 9.3 0.4 mg/dL,
37.713 pg/mL, 8.2 0.6 mg/dL, 290.56 409 pg/mL (median;
116 pg/mL), and 0.9 0.7 mg/dL, respectively. Mean postoperative
serum calcium level was lower than mean preoperative serum
calcium level (9.3 0.4 mg/dL vs. 8.2 0.6 mg/dL, p< 0.001).
In histopathogic evaluation, papillary cancer was detected in 26
patients (16%), of whom 20 (76%) had papillary microcarcinoma
(<1 cm). Mean SD size of all tumors was 6.5 4.3 mm (range
2–17 mm).
The mean SD age was 47.113 years (range, 25–75 years) for
control group. The female to male ratio was 7.3:1 (n¼ 44 and 6,
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PTH levels were 9.2 0.3 mg/dL, 36.613 pg/mL, respectively. No
signiﬁcant difference was found in terms of demographic features,
surgical indications, and preoperative serum calcium and PTH
levels between the study group and control group (Table 1).
There was no operative mortality. The incidence of transient
vocal cord paralysis was 4.3% (7/160). Persistent vocal cord paral-
ysis and hypoparathyroidism were not encountered in our series.
4.2. Postoperative hypocalcemia
In 38 (23.7%) out of 160 patients, serum calcium level was found
to be lower than 8 mg/dL at the postoperative 24th h. Patients in
Group 1 were signiﬁcantly older than those in Group 2 (p¼ 0.001).
No signiﬁcant difference was found in terms of preoperative serum
calcium and PTH levels between Group 1 and Group 2 (p> 0.05).
Postoperative serum calcium level in Group 1 was signiﬁcantly
lower than that in Group 2 (p¼ 0.001). The postoperative drop in
serum calcium level and irPTH levels in Group 1 were signiﬁcantly
higher than those in Group 2 (p¼ 0.001) (Table 2). The irPTH
level in control group (8.3 3.6 pg/mL) was signiﬁcantly lower
than that in Group 1 and Group 2 (803.26 515 pg/mL and
130.87174 pg/mL).
Of 38 patients, 27 (71%) developed symptomatic hypocalcemia
and 11 (29%) developed asymptomatic hypocalcemia. The post-
operative drop in serum calcium level and irPTH level in patients
with symptomatic hypocalcemia (2.3 0.3 mg/dL and
1010 486 pg/mL, respectively) were signiﬁcantly higher than
those in patients with asymptomatic hypocalcemia (1.10.3 mg/dL
and 293122 pg/mL, respectively) (p¼ 0.001). Hospital stay was
signiﬁcantly longer in Group 1 (3.61.1 days, range 2–6 days)
compared with that in Group 2 (1.3 0.4 days, range 1–2 days)
(p¼ 0.001).
4.3. Correlations
There was a negative correlation between age and postoperative
serum calcium level (r¼0.236, p¼ 0.033) whereas a positive
correlation was found between age and irPTH level (r¼0.212,
p¼ 0.007) and postoperative drop in serum calcium level
(r¼0.239, p¼ 0.002). There was a negative correlation between
irPTH level and postoperative serum calcium level (r¼0.641,
p¼ 0.0001) while a positive correlation was found between irPTH
level and postoperative drop in serum calcium level (r¼ 0.781,
p¼ 0.0001) (Fig. 1).
4.4. Evaluation of cut-off values for irPTH based on hypocalcemia
and the difference in serum calcium level
The optimal cut-off value for irPTH based on hypocalcemia
(sensitivity: 94%; speciﬁcity: 81%) was 250 pg/mL. An irPTH level
higher than 250 pg/mL signiﬁcantly correlated with postoperativeTable 2
A comparison of laboratory features in patients with hypocalcemia and patients with no
Features Patients with hypoca
Age 54.2 13
F/M 38/4
Preoperative serum calcium level (mg/dL) 9.4 0.3
Preoperative serum PTH level (pg/dL) 39.7 12
Postoperative serum calcium level (mg/dL) 7.4 0.4
Irrigation ﬂuid PTH level (pg/mL) 803.26 515
The postoperative drop in serum calcium level (pg/mL) 2 0.6
Abbreviations: F: female, M: male, PTH: parathormone.hypocalcemia (p¼ 0.03) (Fig. 2A). The optimal cut-off value for the
postoperative drop in serum calcium level based on hypocalcemia
(sensitivity: 94%; speciﬁcity: 81%) was 1 mg/dL. An irPTH level
higher than 250 pg/mL signiﬁcantly correlated with the post-
operative drop in serum calcium level (p¼ 0.03) (Fig. 2B).
According to ROC analysis, when the irPTH level was more than
250 pg/mL, hypocalcemia was detected in 94% of patients. False
positive high PTH level ratio was 6%. Of 38 patients with hypocal-
cemia, 36 patients had PTH level higher than 250 pg/mL and 2
patients had PTH level lower than 250 pg/mL. Although the irPTH
level was not increased in these 2 patients, the postoperative
hypocalcemia was detected.
The postoperative drop in serum calcium level was found to be
above 1 mg/dL in all of these patients. Patients who had an irPTH
level higher than 250 pg/mL had a 69-fold increased risk for post-
operative hypocalcemia (OR¼ 69.88; 95% CI:15.37–309.94).
The positive predictive value (PPV), negative predictive value
(NPV) and overall accuracy of irPTH in postoperative hypocalcemia
and the postoperative drop in serum calcium level were 61%, 99%,
and 84%, respectively.4.5. Evaluation of cut-off values for irPTH based
on symptomatic hypocalcemia
The optimal cut-off value for irPTH based on symptomatic
hypocalcemia (sensitivity: 96%; speciﬁcity: 90%) was 450 pg/mL.
The PPV, NPV and overall accuracy of irPTH in postoperative
symptomatic hypocalcemia were 96%, 92%, and 97%, respectively.5. Discussion
We investigated the predictive value of irPTH level in devel-
oping postoperative hypocalcemia after thyroidectomy and found
that high irPTH level was signiﬁcantly associated with post-
operative hypocalcemia. The irPTH level in patients with hypocal-
cemia was signiﬁcantly higher than that in patients with
normocalcemia. When the irPTH level was higher than 250 pg/mL
hypocalcemia was detected in 94% of patients. The postoperative
PTH assay in the irrigation ﬂuid was sufﬁcient to identify hypo-
calcemia in the majority of patients.
We suggest that irPTH levels are based on indirect evaluations
of postsurgical residual parathyroid gland function. The exact
mechanism of increase in irPTH levels in surgical site is not yet
clear. The irPTH level in control group was found as 8.3 3.6 pg/
mL (before thyroid dissection and thyroidectomy). After thyroid-
ectomy, mean irPTH level in patients with normocalcemia was
130.87174 pg/mL, whereas mean irPTH level in patients with
hypocalcemia was 803.26 515 pg/mL. The irPTH level in patients
with normocalcemia was signiﬁcantly higher than that in control
group. irPTH level slightly increased in patients who even did not
develop hypocalcaemia after thyroidectomy. Postoperative hypo-
calcemia was not detected in these patients despite a slightrmocalcemia.
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Fig. 1. Correlations between age and postoperative serum calcium level (A), and irPTH (B), postoperative drop in serum calcium level (C), postoperative serum calcium level and
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Fig. 2. (A). ROC curve for the PTH levels of the surgical site irrigation ﬂuid predicting
postoperative hypocalcemia; (B). ROC curve for the PTH levels of the surgical site
irrigation ﬂuid predicting the postoperative drop in serum calcium level. ‘‘cut-off
values of irPTH¼ 250 pg/mL; cut-off values of postoperative drop in serum calcium
level 1 mg/dL’’.
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glands may be subjected to surgical trauma during thyroidectomy.
Thyroidectomy carries potential risk to all four parathyroid
glands and both recurrent laryngeal nerve.4–6 Postoperative
hypocalcemia is one of the most frequent complications after
thyroidectomy. Biochemical hypocalcemia has been reported in as
many as 50% of cases, but symptomatic hypocalcemia is seen much
less frequently.4–8 Improvements in surgical technique cannot
eliminate the risk of hypocalcemia; therefore, hypocalcemia may
occur even in the hands of the more experienced thyroid
surgeons.5–10 The causes of hypocalcemia after TT are multifacto-
rial, and some of the factors involve iatrogenic surgical trauma toparathyroid glands, inadvertent removal of parathyroid glands, the
number of functioning glands left behind, the extent of surgery, the
experience of the surgeon, hyperthyroidism, retrosternal goiter,
concomitant neck dissection, and thyroid carcinoma.4–7,23–29
Hypocalcemia is the principal factor that determines length of
hospital stay after thyroid surgery. Identifying patients with low
risk of hypocalcaemia may facilitate early discharge. The symptoms
of hypocalcemia usually manifest 24–48 h after the thyroid oper-
ations.10,11 Close monitoring of serum calcium levels is commonly
used to identify postoperative hypocalcemia, however, there is no
consensus about the optimal postoperative time.30,31
An intraoperative or postoperative serum PTH assay has been
increasingly adopted to monitor the identiﬁcation of patients who
are at risk for hypocalcemia.15–20 Investigators evaluated the
applicability of intraoperative PTH (ioPTH) assay to identify post-
operative hypocalcemia compared with postoperative serum
calcium monitoring.17,19,32 Both the ioPTH assay and consecutive
early calcium measurements are accurate in predicting post-
operative normocalcemia.17,19,32 However, the ioPTH assay is
available within 15–20 min after operation, but serum calcium
monitoring requires at least 24 h.17,19 The ioPTH assay monitors
parathyroid function during thyroidectomy and identify patients at
risk of clinically signiﬁcant hypocalcemia much earlier than serum
calcium monitoring.15–22,32
The accuracy of low intraoperative and postoperative serum
PTH levels in predicting biochemical and symptomatic post-
operative hypocalcemia was effective.15–22 In addition to its clinical
usefulness in identiﬁcation of patients to be treated, serum PTH
assay may also be cost-effective by reducing postoperative hospital
stay and the need for expensive postoperative serum calcium
monitoring. The sensitivity of the ioPTH level in predicting post-
operative hypocalcemia is 70–80%.15–18 In several studies, low
serum PTH levels 8 and 12 h after operation were found to be the
most accurate (98%) predictors of postoperative hypocalcemia.19–22
On the contrary, Lombardi et al.33 evaluated the reliability of PTH
levels 4 h after thyroidectomy as a predictor of hypocalcemia in
a large series of patients. In this study, false-negative results were
observed in %13.4 of the patients. They found that low 4 h-PTH
levels alone did not accurately predict clinically-relevant post-
operative hypocalcemia.
In previous studies, the use of the intraoperative and post-
operative serum PTH assay provided a way to assess overall para-
thyroid function during thyroidectomy.19,22,34–36 Although efforts
have been made for the use of perioperative PTH level in predicting
postoperative hypocalcemia, ﬁndings on the accuracy of serum PTH
monitoring and the optimal postoperative time remained obscure.
To our knowledge, our study is the ﬁrst prospective study per-
formed to detect the value of irPTH level in predicting post-
operative hypocalcemia after thyroidectomy.
PTH is made by the parathyroid gland and is critical to calcium
and phosphorus balance. Parathyroid gland dysfunction results in
low serum PTH and calcium levels. The most probable cause is
certainly postoperative hypocalcemia secondary to trauma and
devascularization during thyroidectomy.7,10,11 Therefore we suggest
that parathyroid gland destruction by surgical trauma contributes
to the release of PTH to the surgical site and irPTH assay can identify
patients at risk of hypocalcemia much earlier than perioperative
PTH monitoring. In our study, we didn’t compare the predictive
value of postoperative hypocalcemia of irPTH and ioPTH, however,
recent studies showed that the sensitivity of ioPTH level in pre-
dicting postoperative hypocalcemia is 70% to 80%. For this reason,
we consider that the predictive value of irPTH level could be higher
than ioPTH level. A study for comparing the predictive value of
irPTH with ioPTH is currently being conducted in our clinic. In our
study, irPTH was strongly useful to predict hypocalcemia after
E. Kamer et al. / International Journal of Surgery 7 (2009) 466–471 471thyroidectomy. Based on the results of the study, we recommend
that patients with irPTH levels higher than 250 pg/dL should
immediately be placed on oral calcium and, if necessary, vitamin D
supplementation in order to prevent symptomatic hypocalcemia.6. Conclusion
irPTH assay is a sensitive tool in predicting postoperative
hypocalcemia and identifying patients at risk of developing post-
operative hypocalcemia.Conﬂict of interest
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